Recent Finacing
Recent Raise
Asuragen develops blood-based molecular diagnostics that use circulating microRNA biomarkers for early cancer detection and monitoring, and operates preclinical programs for microRNA-based cancer therapies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors